Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Hanne Vestergaard"'
Autor:
Fabio Efficace, Francois-Xavier Mahon, Johan Richter, Alfonso Piciocchi, Marta Cipriani, Franck Emmanuel Nicolini, Henrik Hjorth-Hansen, Antonio Almeida, Jeroen J. W. M. Janssen, Jiri Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson-Strömberg, Joaquín Martinez-Lopez, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Katerina Machova Polakova, Satu Mustjoki, Marc Berger, Andreas Hochhaus, Markus Pfirrmann, Susanne Saussele
Publikováno v:
HemaSphere, Vol 7, p e0972454 (2023)
Externí odkaz:
https://doaj.org/article/a078e335813f413cb617882efe61628c
Autor:
Markus Pfirrmann, Francois-Xavier Mahon, Stéphanie Dulucq, Andreas Hochhaus, Panayiotis Panayiotidis, Antonio Almeida, Jiri Mayer, Henrik Hjorth-Hansen, Jeroen J. W. M. Janssen, Satu Mustjoki, Joaquín Martinez-Lopez, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Franck Emmanuel Nicolini, Wolf-Karsten Hofmann, Joëlle Guilhot, Susanne Saussele, Johan Richter
Publikováno v:
HemaSphere, Vol 7, p e230884b (2023)
Externí odkaz:
https://doaj.org/article/f21cdde0c6114e2fb555ae09f10c9dbe
Autor:
Gunhild Nynke Thomsen, Mette Niemann Christoffersen, Hanne Merete Lindegaard, Jesper Rømhild Davidsen, Gitte Nyvang Hartmeyer, Kristian Assing, Charlotte G. Mortz, Raquel Martin-Iguacel, Michael Boe Møller, Anette Drøhse Kjeldsen, Troels Havelund, Daniel El Fassi, Sigurd Broesby-Olsen, Michael Maiborg, Sofie Lock Johansson, Christen Lykkegaard Andersen, Hanne Vestergaard, Ole Weis Bjerrum
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Eosinophilic granulocytes are normally present in low numbers in the bloodstream. Patients with an increased number of eosinophilic granulocytes in the differential count (eosinophilia) are common and can pose a clinical challenge because conditions
Externí odkaz:
https://doaj.org/article/2b8584069f364c14a011c10e2a0b3072
Autor:
Celalettin Ustun, Elizabeth Morgan, Erica E. M. Moodie, Sheeja Pullarkat, Cecilia Yeung, Sigurd Broesby‐Olsen, Robert Ohgami, Young Kim, Wolfgang Sperr, Hanne Vestergaard, Dong Chen, Philip M. Kluin, Michelle Dolan, Krzysztof Mrózek, David Czuchlewski, Hans‐Peter Horny, Tracy I. George, Thomas Kielsgaard Kristensen, Nam K. Ku, Cecilia Arana Yi, Michael Boe Møller, Guido Marcucci, Linda Baughn, Ana‐Iris Schiefer, J. R. Hilberink, Vinod Pullarkat, Ryan Shanley, Jessica Kohlschmidt, Janie Coulombe, Amandeep Salhotra, Lori Soma, Christina Cho, Michael A. Linden, Cem Akin, Jason Gotlib, Gregor Hoermann, Jason Hornick, Ryo Nakamura, Joachim Deeg, Clara D. Bloomfield, Daniel Weisdorf, Mark R. Litzow, Peter Valent, Gerwin Huls, Miguel‐Angel Perales, Gautam Borthakur
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4447-4455 (2018)
Abstract Background Although the prognosis of core‐binding factor (CBF) acute myeloid leukemia (AML) is better than other subtypes of AML, 30% of patients still relapse and may require allogeneic hematopoietic cell transplantation (alloHCT). Howeve
Externí odkaz:
https://doaj.org/article/094eb1a2e98b464ea81e0fe6a9fdcc3c
Autor:
Christen L. Andersen, Nana B. Mortensen, Tobias W. Klausen, Hanne Vestergaard, Ole W. Bjerrum, Hans C. Hasselbalch
Publikováno v:
Haematologica, Vol 99, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/cf18a8addded4daea1634516e06eecf9
Autor:
Christen Lykkegaard Andersen, Hanne Lindegaard, Hanne Vestergaard, Volkert Dirk Siersma, Hans Carl Hasselbalch, Niels de Fine Olivarius, Ole Weis Bjerrum, Peter Junker
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99388 (2014)
BackgroundSeveral studies have demonstrated an association between rheumatoid arthritis (RA) and lymphoproliferative malignancies, but pathogenic mechanisms remain unclear. We investigated 1) the risk of lymphoproliferative malignancies and solid tum
Externí odkaz:
https://doaj.org/article/7747e2bb342f4cf8abb080a5f4fc85d5
Autor:
Lars Möllgård, Leonie Saft, Marianne Bach Treppendahl, Ingunn Dybedal, Jan Maxwell Nørgaard, Jan Astermark, Elisabeth Ejerblad, Hege Garelius, Inge Høgh Dufva, Monika Jansson, Martin Jädersten, Lars Kjeldsen, Olle Linder, Lars Nilsson, Hanne Vestergaard, Anna Porwit, Kirsten Grønbæk, Eva Hellström Lindberg
Publikováno v:
Haematologica, Vol 96, Iss 7 (2011)
Background Patients with chromosome 5 abnormalities and high-risk myelodysplastic syndromes or acute myeloid leukemia have a poor outcome. We hypothesized that increasing doses of lenalidomide may benefit this group of patients by inhibiting the tumo
Externí odkaz:
https://doaj.org/article/141d2a56ccab4820add460edcc817c01
Autor:
Christel Stormhøj, Christina Fiig, Vibeke Rittmann Petersen, Helle Husum, Anita Frank Goth, Hanne Vestergaard Andersen, Rikke Sanderhoff
Publikováno v:
Kvinder, Køn & Forskning, Iss 2 (1998)
I dette nummer anmeldes følgende: "Børn i sammenbraget familier. Et studie af forældreskab som social konstruktion" (Mai Heide Ottosen), "Arbejdsmarkedsstyrelsen 1997" (Ruth Emerek m.fl. (red.)), "Køn & Løn" (Lis Højgaard), "Tegnet på kropppen
Externí odkaz:
https://doaj.org/article/7a6ba65b50ff44919e4e7a509d5edc44
Autor:
Hans-Peter Horny, Cecilia Arana Yi, Celalettin Ustun, Cecilia C. S. Yeung, Jason Gotlib, Christina Cho, Tracy I. George, David R. Czuchlewski, Jessica Kohlschmidt, Amandeep Salhotra, Ryotaro Nakamura, Sheeja T. Pullarkat, Gerwin Huls, Linda B. Baughn, Robert S. Ohgami, Jenna M. Voutsinas, Cem Akin, Wolfgang R. Sperr, Guido Marcucci, Jason L. Hornick, Young L. Kim, Hanne Vestergaard, Qian Wu, Gautam Borthakur, Gregor Hoermann, Mark R. Litzow, Michael Boe Møller, Peter Valent, Dong Chen, Jacobien R. Hilberink, Miguel-Angel Perales, Melissa L. Larson, Thomas Kielsgaard Kristensen, Michael A. Linden, Ana Iris Schiefer, Philip M. Kluin, Daniel J. Weisdorf, Clara D. Bloomfield, Vinod Pullarkat, Michelle M Dolan, Se young Han, Nam K. Ku, H. Joachim Deeg, Krzysztof Mrózek, Sigurd Broesby-Olsen, Elizabeth A. Morgan, Lori Soma
Publikováno v:
Blood, 5(10), 2481-2489. AMER SOC HEMATOLOGY
Blood Adv
Han, S Y, Mrózek, K, Voutsinas, J, Wu, Q, Morgan, E A, Vestergaard, H, Ohgami, R, Kluin, P M, Kristensen, T K, Pullarkat, S, Møller, M B, Schiefer, A I, Baughn, L B, Kim, Y, Czuchlewski, D, Hilberink, J R, Horny, H P, George, T I, Dolan, M, Ku, N K, Yi, C A, Pullarkat, V, Kohlschmidt, J, Salhotra, A, Soma, L, Bloomfield, C D, Chen, D, Sperr, W R, Marcucci, G, Cho, C, Akin, C, Gotlib, J, Broesby-Olsen, S, Larson, M, Linden, M A, Deeg, H J, Hoermann, G, Perales, M A, Hornick, J L, Litzow, M R, Nakamura, R, Weisdorf, D, Borthakur, G, Huls, G, Valent, P, Ustun, C & Yeung, C C S 2021, ' Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) ', Blood Advances, vol. 5, no. 10, pp. 2481-2489 . https://doi.org/10.1182/BLOODADVANCES.2020003605
Blood Adv
Han, S Y, Mrózek, K, Voutsinas, J, Wu, Q, Morgan, E A, Vestergaard, H, Ohgami, R, Kluin, P M, Kristensen, T K, Pullarkat, S, Møller, M B, Schiefer, A I, Baughn, L B, Kim, Y, Czuchlewski, D, Hilberink, J R, Horny, H P, George, T I, Dolan, M, Ku, N K, Yi, C A, Pullarkat, V, Kohlschmidt, J, Salhotra, A, Soma, L, Bloomfield, C D, Chen, D, Sperr, W R, Marcucci, G, Cho, C, Akin, C, Gotlib, J, Broesby-Olsen, S, Larson, M, Linden, M A, Deeg, H J, Hoermann, G, Perales, M A, Hornick, J L, Litzow, M R, Nakamura, R, Weisdorf, D, Borthakur, G, Huls, G, Valent, P, Ustun, C & Yeung, C C S 2021, ' Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21) ', Blood Advances, vol. 5, no. 10, pp. 2481-2489 . https://doi.org/10.1182/BLOODADVANCES.2020003605
Patients with core-binding factor (CBF) acute myeloid leukemia (AML), caused by either t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22), have higher complete remission rates and longer survival than patients with other subtypes of AML. However,
Autor:
Henrik Frederiksen, Sabina Østerlev, Sidse Ehmsen, Isik Somuncu Johansen, Henrik J. Ditzel, Hanne Vestergaard, Anders Asmussen, Stefan Starup Jeppesen, Ulrik Stenz Justesen, Anna Nilsson
Publikováno v:
Ehmsen, S, Asmussen, A, Jeppesen, S S, Nilsson, A C, Østerlev, S, Vestergaard, H, Justesen, U S, Johansen, I S, Frederiksen, H & Ditzel, H J 2021, ' Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer ', Cancer Cell, vol. 39, no. 8, pp. 1034-1036 . https://doi.org/10.1016/j.ccell.2021.07.016